ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 364,40
0,05%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Phio Pharmaceuticals Corporation (PHIO)

  7. Phio Pharmaceuticals Corporation (PHIO) Actualités

PHIO Phio Pharmaceuticals Corporation

0,7345
-0,0155 (-2,07%)
08 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Phio Pharmaceuticals Corporation PHIO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0155 -2,07% 0,7345 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,75 0,72 0,75 0,745 0,75
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/5/202423:00EDGAR2Form 8-K - Current report
20/5/202423:03EDGAR2Form S-3 - Registration statement under Securities Act of..
20/5/202422:59EDGAR2Form RW - Registration Withdrawal Request
17/5/202422:45EDGAR2Form S-3 - Registration statement under Securities Act of..
17/5/202415:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/5/202415:00GLOBEPhio Pharmaceuticals Secures New Investor
17/5/202415:00EDGAR2Form 8-K - Current report
16/5/202414:00GLOBEPhio Pharmaceuticals Presents This Week at the Society for..
15/5/202419:00GLOBEPhio Pharmaceuticals Announces Completion of Dosing in First..
09/5/202423:25GLOBEPhio Pharmaceuticals Reports Q1 2024 Results and Provides..
09/5/202423:23EDGAR2Form 8-K - Current report
09/5/202423:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202423:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/5/202423:02EDGAR2Form DEF 14A - Other definitive proxy statements
08/5/202423:00EDGAR2Form ARS - Annual Report to Security Holders
30/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
22/4/202419:10GLOBEIntratumoral Injection of Phio’s PH-762 significantly..
16/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentations at the..
11/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
03/4/202413:30GLOBENational Spotlight Features Phio’s Innovative RNAi..
02/4/202413:30GLOBEPhio Pharmaceuticals Reports 2023 Year End Financial Results..
21/3/202412:30GLOBEPhio Pharmaceuticals Presenting Data Showing INTASYL May..
13/3/202419:00GLOBEPhio Pharmaceuticals Announces Addition of Clinical Trial..
06/3/202416:30GLOBEPhio Pharmaceuticals Announces Patent Granted by USPTO,..
06/3/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202414:00GLOBEPhio Pharmaceuticals Announces Data Showing INTASYL May..
26/1/202423:00EDGAR2Form 8-K - Current report
28/12/202315:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/12/202322:52EDGAR2Form S-1 - General form for registration of securities under..
08/12/202323:00EDGAR2Form 8-K - Current report
07/12/202314:00GLOBEPhio Pharmaceuticals Announces Exercise of Warrants for $2.8..
09/11/202322:40EDGAR2Form 8-K - Current report
09/11/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:30GLOBEPhio Pharmaceuticals Reports Third Quarter 2023 Financial..
09/11/202313:30GLOBEPhio Pharmaceuticals Announces First US Patient Enrolled in..
03/11/202317:00GLOBEPhio Pharmaceuticals Presents New Data Showing INTASYL..
12/10/202317:00GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
11/10/202313:30GLOBEPhio Pharmaceuticals Presents New Data for Targeting of BRD4..
06/9/202313:30GLOBEPhio CEO to Speak at Wainwright Conference in New York in..
21/8/202313:30GLOBEPhio Pharmaceuticals Announces Dosing of First Patient in..
21/8/202313:30EDGAR2Form 8-K - Current report
10/8/202322:40EDGAR2Form 8-K - Current report
10/8/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:30GLOBEPhio Pharmaceuticals Reports Second Quarter 2023 Financial..
26/7/202322:30EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
PHIO
Phio Pharmaceuticals
NYSE
BFO
BlackRock Florida Muni 2...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés